Response Biomedical Signs Second China Partner

Response Biomedical Corporation signed up a second partner to market its diagnostic products in China. Guangzhou Wondfo Biotech Co., Ltd. (Wondfo) in China will sell Response Biomedical’s cardiac offerings as private label products. O&D Biotech Co. will continue to market the same diagnostic tests as co-branded RAMP® products on both the RAMP® and RAMP® 200 Readers. More details... Stock Symbol: (TSX: RBM, OTCBB: RPBIF)